• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[阿尔茨海默综合征发病机制的新假说。晚期糖基化终末产物(AGEs)]

[New hypothesis on etiopathogenesis of Alzheimer syndrome. Advanced glycation end products (AGEs)].

作者信息

Thome J, Kornhuber J, Münch G, Schinzel R, Taneli Y, Zielke B, Rösler M, Riederer P

机构信息

Psychiatrische Klinik und Poliklinik, Universitäts-Nervenklinik, Würzburg.

出版信息

Nervenarzt. 1996 Nov;67(11):924-9. doi: 10.1007/s001150050073.

DOI:10.1007/s001150050073
PMID:9064552
Abstract

Despite intense efforts, it has not yet been possible to clarify the etiopathogenesis of Alzheimer's dementia. There are, however, hypotheses which focus on certain aspects of this type of dementia, characterized by particular neuropathological alterations and clinical correlates. Recently, evidence has accumulated that advanced glycation endproducts (AGEs) could play an important role in the etiology of the Alzheimer's syndrome. AGEs are generated by an irreversible reaction through the non-enzymatic, long-term glycosylation of proteins. They are strongly resistant to proteolytic processes and induce protein crosslinking. They could thus inhibit the physiological functions of many proteins. Moreover, it is suggested that they contribute to the transformation of the soluble form of beta-amyloid into its unsoluble version. AGEs are also demonstrable in neurofibrillary tangles (NFTs). A further mechanism by which AGEs might be pathogenic is via their induction of oxidative stress. AGEs probably exert their pathological effects not only directly because of their chemical properties, but also by indirect receptor-mediated mechanisms. Further investigation of AGE-mediated mechanisms should reveal their role in the etiopathogenesis of the Alzheimer's syndrome and, finally, lead to the development of new pharmacological strategies aimed at inhibiting protein cross-linking.

摘要

尽管付出了巨大努力,但仍未能阐明阿尔茨海默病性痴呆的病因发病机制。然而,有一些假说聚焦于这类痴呆的某些方面,其特征为特定的神经病理学改变和临床相关表现。最近,越来越多的证据表明晚期糖基化终末产物(AGEs)可能在阿尔茨海默综合征的病因中起重要作用。AGEs是通过蛋白质的非酶促长期糖基化的不可逆反应产生的。它们对蛋白水解过程具有很强的抗性,并诱导蛋白质交联。因此,它们可能会抑制许多蛋白质的生理功能。此外,有人认为它们有助于β-淀粉样蛋白的可溶性形式转化为不溶性形式。在神经原纤维缠结(NFTs)中也可检测到AGEs。AGEs可能致病的另一种机制是通过诱导氧化应激。AGEs可能不仅因其化学性质直接发挥病理作用,还通过间接的受体介导机制发挥作用。对AGE介导机制的进一步研究应能揭示它们在阿尔茨海默综合征病因发病机制中的作用,并最终导致旨在抑制蛋白质交联的新药理学策略的开发。

相似文献

1
[New hypothesis on etiopathogenesis of Alzheimer syndrome. Advanced glycation end products (AGEs)].[阿尔茨海默综合征发病机制的新假说。晚期糖基化终末产物(AGEs)]
Nervenarzt. 1996 Nov;67(11):924-9. doi: 10.1007/s001150050073.
2
Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease.晚期糖基化终产物(AGEs)可能参与阿尔茨海默病的发病机制。
Curr Pharm Des. 2008;14(10):973-8. doi: 10.2174/138161208784139693.
3
Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.阿尔茨海默病及其他神经退行性疾病中的晚期糖基化终末产物
Am J Pathol. 1998 Oct;153(4):1149-55. doi: 10.1016/S0002-9440(10)65659-3.
4
Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease.阿尔茨海默病中的晚期糖基化终产物及其受体 RAGE。
Neurobiol Aging. 2011 May;32(5):763-77. doi: 10.1016/j.neurobiolaging.2009.04.016. Epub 2009 May 22.
5
Effect of advanced glycation endproducts on cell cycle and their relevance for Alzheimer's disease.晚期糖基化终产物对细胞周期的影响及其与阿尔茨海默病的相关性。
J Neural Transm Suppl. 2003(65):63-71. doi: 10.1007/978-3-7091-0643-3_4.
6
[Non-enzymatic glycation and oxidative stress in chronic illnesses and diabetes mellitus].慢性病与糖尿病中的非酶糖基化和氧化应激
Med Klin (Munich). 1999 Jan 15;94(1):29-38. doi: 10.1007/BF03044692.
7
The role of the Maillard reaction in other pathologies: Alzheimer's disease.美拉德反应在其他病理学中的作用:阿尔茨海默病。
Nephrol Dial Transplant. 1996;11 Suppl 5:7-12. doi: 10.1093/ndt/11.supp5.7.
8
Serum or cerebrospinal fluid levels of glyceraldehyde-derived advanced glycation end products (AGEs) may be a promising biomarker for early detection of Alzheimer's disease.甘油醛衍生的晚期糖基化终产物(AGEs)的血清或脑脊液水平可能是早期检测阿尔茨海默病的一种有前景的生物标志物。
Med Hypotheses. 2005;64(6):1205-7. doi: 10.1016/j.mehy.2005.01.016.
9
Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress.阿尔茨海默病中的糖化tau蛋白:诱导氧化应激的一种机制。
Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7787-91. doi: 10.1073/pnas.91.16.7787.
10
Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.从紊乱的大脑葡萄糖代谢解码阿尔茨海默病:对诊断和治疗策略的影响。
Prog Neurobiol. 2013 Sep;108:21-43. doi: 10.1016/j.pneurobio.2013.06.004. Epub 2013 Jul 11.

引用本文的文献

1
From the Bush to the Brain: Preclinical Stages of Ethnobotanical Anti-Inflammatory and Neuroprotective Drug Discovery-An Australian Example.从灌木到大脑:民族植物学抗炎和神经保护药物发现的临床前阶段——澳大利亚范例。
Int J Mol Sci. 2023 Jul 4;24(13):11086. doi: 10.3390/ijms241311086.
2
A multitude of signaling pathways associated with Alzheimer's disease and their roles in AD pathogenesis and therapy.与阿尔茨海默病相关的众多信号通路及其在 AD 发病机制和治疗中的作用。
Med Res Rev. 2021 Sep;41(5):2689-2745. doi: 10.1002/med.21719. Epub 2020 Aug 11.
3
Gut Microbiota Disorder, Gut Epithelial and Blood-Brain Barrier Dysfunctions in Etiopathogenesis of Dementia: Molecular Mechanisms and Signaling Pathways.
肠道微生物紊乱、肠道上皮和血脑屏障功能障碍在痴呆发病机制中的作用:分子机制和信号通路。
Neuromolecular Med. 2019 Sep;21(3):205-226. doi: 10.1007/s12017-019-08547-5. Epub 2019 May 21.
4
Current Perspectives and Mechanisms of Relationship between Intestinal Microbiota Dysfunction and Dementia: A Review.肠道微生物群功能障碍与痴呆症关系的当前观点及机制:综述
Dement Geriatr Cogn Dis Extra. 2018 Oct 18;8(3):360-381. doi: 10.1159/000492491. eCollection 2018 Sep-Dec.
5
Positive Feedback Loops in Alzheimer's Disease: The Alzheimer's Feedback Hypothesis.阿尔茨海默病中的正反馈环:阿尔茨海默病反馈假说。
J Alzheimers Dis. 2018;66(1):25-36. doi: 10.3233/JAD-180583.
6
Effects of RAGE-Specific Inhibitor FPS-ZM1 on Amyloid-β Metabolism and AGEs-Induced Inflammation and Oxidative Stress in Rat Hippocampus.RAGE特异性抑制剂FPS-ZM1对大鼠海马中淀粉样蛋白-β代谢及晚期糖基化终末产物诱导的炎症和氧化应激的影响
Neurochem Res. 2016 May;41(5):1192-9. doi: 10.1007/s11064-015-1814-8. Epub 2016 Jan 6.
7
Role of RAGE in Alzheimer's Disease.晚期糖基化终末产物受体在阿尔茨海默病中的作用。
Cell Mol Neurobiol. 2016 May;36(4):483-95. doi: 10.1007/s10571-015-0233-3. Epub 2015 Jul 15.
8
Chronic neuroinflammation in Alzheimer's disease: new perspectives on animal models and promising candidate drugs.阿尔茨海默病的慢性神经炎症:动物模型和有前途的候选药物的新视角。
Biomed Res Int. 2014;2014:309129. doi: 10.1155/2014/309129. Epub 2014 Jun 16.
9
Induced pluripotent stem cells as tools for disease modelling and drug discovery in Alzheimer's disease.诱导多能干细胞作为阿尔茨海默病疾病建模和药物发现的工具。
J Neural Transm (Vienna). 2013 Jan;120(1):103-11. doi: 10.1007/s00702-012-0839-2. Epub 2012 Jun 13.
10
Oxidative stress in Alzheimer disease.阿尔茨海默病中的氧化应激。
Cell Adh Migr. 2009 Jan-Mar;3(1):88-93. doi: 10.4161/cam.3.1.7402. Epub 2009 Jan 13.